← Leaderboards
Harold H Koeffler
University Of California Los Angeles
$10,694,831
Attributed
$10,694,831
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$12,586,079 · 12
By mechanism
R01$8,313,920 · 4
U54$3,648,546 · 3
U56$326,750 · 1
R21$120,300 · 1
P01$96,363 · 1
R03$80,200 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Judith Cheryl Gasson$28,230,504
- Kenneth Allan Dorshkind$13,544,292
- Harvey R. Herschman$16,718,124
- David None Heber$3,384,583
- Gayle Cocita Baldwin$3,748,817
Others in their field
Top investigators on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$278,513,775
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
Research focus
InsightUniversitiesMalignant NeoplasmsSamplingGenomicsCell LineNovel TherapeuticsGene TargetingLeadTranscription FactorResearch PersonnelCellsLaboratory MouseProteinsResistanceGenesAffectCell DifferentiationOutcome ForecastDiagnosisGeneticBaseAdultCancer Center
Grant awards (43)
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches$363,125
R01 · FY2020 · CA · contact PI
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches$352,231
R01 · FY2019 · CA · contact PI
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches$363,125
R01 · FY2018 · CA · contact PI
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches$363,125
R01 · FY2017 · CA · contact PI
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches$363,125
R01 · FY2016 · CA · contact PI
Pax5:Hematopoietic Transcription Factor Involved in ALL$343,368
R01 · FY2013 · CA · contact PI
Administrative Core$70,225
U54 · FY2013 · CA · contact PI
Pax5:Hematopoietic Transcription Factor Involved in ALL$365,285
R01 · FY2012 · CA · contact PI
Administrative Core$76,443
U54 · FY2012 · CA · contact PI
Pax5:Hematopoietic Transcription Factor Involved in ALL$365,285
R01 · FY2011 · CA · contact PI
Administrative Core$364,423
U54 · FY2011 · CA · contact PI
CCN Proteins and Breast Cancer$160,564
U54 · FY2011 · CA · contact PI
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health$950,808
U54 · FY2010 · CA · contact PI
Administrative Core$379,612
U54 · FY2010 · CA · contact PI
Pax5:Hematopoietic Transcription Factor Involved in ALL$376,582
R01 · FY2010 · CA · contact PI
CCN Proteins and Breast Cancer$166,228
U54 · FY2010 · CA · contact PI
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health$940,440
U54 · FY2009 · CA · contact PI
Pax5:Hematopoietic Transcription Factor Involved in ALL$376,582
R01 · FY2009 · CA · contact PI
Administrative Core$376,129
U54 · FY2009 · CA · contact PI
CCN Proteins and Breast Cancer$163,674
U54 · FY2009 · CA · contact PI
Investigating the Role of Cyr61 in Breast Cancer$297,342
R01 · FY2008 · CA · contact PI
Drew/UCLA Cancer Partnership Program$200,000
U56 · FY2008 · CA · contact PI
C/EBP-epsilon: Role in Myeloid Development$344,240
R01 · FY2007 · CA · contact PI
Investigating the Role of Cyr61 in Breast Cancer$303,229
R01 · FY2007 · CA · contact PI
C/EBP-epsilson: Role in Myeloid Development$354,521
R01 · FY2006 · CA · contact PI
Investigating the Role of Cyr61 in Breast Cancer$287,478
R01 · FY2006 · CA · contact PI
C/EBP-epsilson: Role in Myeloid Development$363,052
R01 · FY2005 · CA
Investigating the Role of Cyr61 in Breast Cancer$267,634
R01 · FY2005 · CA
Drew/UCLA Cancer Partnership Program$50,000
U56 · FY2005 · CA
C/EBP-epsilson: Role in Myeloid Development$363,052
R01 · FY2004 · CA
Investigating the Role of Cyr61 in Breast Cancer$243,304
R01 · FY2004 · CA
Drew/UCLA Cancer Partnership Program$76,750
U56 · FY2004 · CA
C/EBP-epsilon: Role in Myeloid Development$363,052
R01 · FY2003 · CA
C/EBPE--STUDY OF A NOVEL MYELOID TRANSCRIPTION FACTOR$380,612
R01 · FY2002 · CA
CORE--MOLECULAR ONCOLOGY$0
P30 · FY2002 · CA
C/EBPE--STUDY OF A NOVEL MYELOID TRANSCRIPTION FACTOR$369,528
R01 · FY2001 · CA
HHV-8 IN PRIMARY EFFUSION LYMPHOMAS$195,993
R01 · FY2001 · CA
CORE--CELLULAR AND MOLECULAR BIOLOGY$0
P01 · FY2001 · CA
C/EBPE--STUDY OF A NOVEL MYELOID TRANSCRIPTION FACTOR$358,767
R01 · FY2000 · CA
HHV-8 IN PRIMARY EFFUSION LYMPHOMAS$190,283
R01 · FY2000 · CA
IDENTIFICATION OF NOVEL SECRETED MOLECULES OF CANCER$120,300
R21 · FY2000 · CA
CORE--CELLULAR AND MOLECULAR BIOLOGY$96,363
P01 · FY2000 · CA
DISCOVERY OF NEW SECRETED PROTEINS OF PANCREATIC CANCER$80,200
R03 · FY2000 · CA